Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial
Increasing investment in research and development has strengthened the competitive landscape, while strategic collaborations among pharmaceutical manufacturers have broadened commercial reach
Pancreatic cancer (No prior history of cancer) Esophageal injury requiring surgery
Assay performance and Validation of NADMED Assay Against Mass-Spectrometry NADMED assays demonstrated high precision with intra-assay coefficients of variation (CV%) ranging from 2.28 to 9.02, and inter-assay precision from 3.93 to 9.37
After successful model establishment, the experimental group received 4 weeks of gavage administration with the test samples, during which the animals had free access to food
US$ 25.92
-1775582746855.png&w=384&q=75)
US$ 26.03
US$ 28.73
US$ 27.60
US$ 29.84
US$ 25.69
US$ 21.68
US$ 24.83
